These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 25262796)

  • 1. Recent advances in computer-aided drug design as applied to anti-influenza drug discovery.
    Mallipeddi PL; Kumar G; White SW; Webb TR
    Curr Top Med Chem; 2014; 14(16):1875-89. PubMed ID: 25262796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent progress and challenges in the discovery of new neuraminidase inhibitors.
    Chamni S; De-Eknamkul W
    Expert Opin Ther Pat; 2013 Apr; 23(4):409-23. PubMed ID: 23369206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating molecular modelling methods to advance influenza A virus drug discovery.
    Patel H; Kukol A
    Drug Discov Today; 2021 Feb; 26(2):503-510. PubMed ID: 33220433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of potential drugs for human-infecting H7N9 virus containing R294K mutation.
    He JY; Li C; Wu G
    Drug Des Devel Ther; 2014; 8():2377-90. PubMed ID: 25489236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in pharmacophore modeling and its application to anti-influenza drug discovery.
    Shin WJ; Seong BL
    Expert Opin Drug Discov; 2013 Apr; 8(4):411-26. PubMed ID: 23373617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Advances in Application of Computer-Aided Drug Design in Anti-Influenza A Virus Drug Discovery.
    Yu D; Wang L; Wang Y
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in neuraminidase inhibitor development as anti-influenza drugs.
    Feng E; Ye D; Li J; Zhang D; Wang J; Zhao F; Hilgenfeld R; Zheng M; Jiang H; Liu H
    ChemMedChem; 2012 Sep; 7(9):1527-36. PubMed ID: 22807317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-influenza drugs: the development of sialidase inhibitors.
    von Itzstein M; Thomson R
    Handb Exp Pharmacol; 2009; (189):111-54. PubMed ID: 19048199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral M2 ion channel protein: a promising target for anti-influenza drug discovery.
    Moorthy NS; Poongavanam V; Pratheepa V
    Mini Rev Med Chem; 2014; 14(10):819-30. PubMed ID: 25342196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanded table: Antiviral drugs for treatment and prophylaxis of seasonal influenza 2018-2019.
    Med Lett Drugs Ther; 2019 Jan; 61(1563):e11-e12. PubMed ID: 30681664
    [No Abstract]   [Full Text] [Related]  

  • 11. Influenza virus resistance to antiviral therapy.
    van der Vries E; Schutten M; Fraaij P; Boucher C; Osterhaus A
    Adv Pharmacol; 2013; 67():217-46. PubMed ID: 23886002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral drugs for treatment and prophylaxis of seasonal influenza.
    Med Lett Drugs Ther; 2019 Jan; 61(1563):1-4. PubMed ID: 30681660
    [No Abstract]   [Full Text] [Related]  

  • 13. From neuraminidase inhibitors to conjugates: a step towards better anti-influenza drugs?
    Cheng CK; Tsai CH; Shie JJ; Fang JM
    Future Med Chem; 2014 May; 6(7):757-74. PubMed ID: 24941871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods.
    Nguyen HT; Fry AM; Gubareva LV
    Antivir Ther; 2012; 17(1 Pt B):159-73. PubMed ID: 22311680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening methods for influenza antiviral drug discovery.
    Atkins C; Evans CW; White EL; Noah JW
    Expert Opin Drug Discov; 2012 May; 7(5):429-38. PubMed ID: 22435452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type II transmembrane serine proteases as potential target for anti-influenza drug discovery.
    Shin WJ; Seong BL
    Expert Opin Drug Discov; 2017 Nov; 12(11):1139-1152. PubMed ID: 28870104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational screening of known broad-spectrum antiviral small organic molecules for potential influenza HA stem inhibitors.
    Mathew S; Al Thani AA; Yassine HM
    PLoS One; 2018; 13(9):e0203148. PubMed ID: 30180218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel antiviral drug discovery strategies to tackle drug-resistant mutants of influenza virus strains.
    Shin WJ; Seong BL
    Expert Opin Drug Discov; 2019 Feb; 14(2):153-168. PubMed ID: 30585088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress of small molecular inhibitors in the development of anti-influenza virus agents.
    Wu X; Wu X; Sun Q; Zhang C; Yang S; Li L; Jia Z
    Theranostics; 2017; 7(4):826-845. PubMed ID: 28382157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.